Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 44, Issue 12, 2003, Pages 2089-2093

  Hazar, Burhan ^a   Paydas, Semra ^b   Zorludemir, Suzan ^b   Sahin, Berksoy ^b   Tuncer, Ilhan ^b  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Angiogenesis; Lymphoma; Microvessel density; Prognosis; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 8 ANTIBODY; MONOCLONAL ANTIBODY; PARAFFIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANGIOGENESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TISSUE SECTION; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0242550768     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000123519     Document Type: Article

References (45)

1. Ellis, L.M. and Fidler, I.J. (1996) "Angiogenesis and metastasis", Eur. J. Cancer 32A(14), 2413-2422.
2. Fidler, I.J., Kumar, R., Bilenberg, D.R. and Ellis, L.K. (1998) "Molecular determinants of angiogenesis in cancer metastasis. Molecular determinants of angiogenesis in cancer metastasis", Cancer J. Sci. Am., Suppl., 58-66.
3. Folkman, J. (1995) "Clinical applications of angiogenesis", N. Engl. J. Med. 333(26), 1757-1763.
4. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltrak, Z. (1999) "Vascular endothelial growth factor (VEGF) and its receptors", FASEB J. 13, 9-22.
5. Mattern, J., Koomagi, R. and Volm, M. (1996) "Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid carcinoma", Br. J. Cancer 73, 931-934.
6. Olson, T.A., Mobanraj, D., Carson, L.F. and Ramorkrishnon, S. (1994) "Vascular permeability factor gene expression in normal and neoplastic human ovaries", Cancer Res. 54, 276-280.
7. Salven, P., Heikkila, P. and Joensuu, H. (1997) "Enhnced expression of endothelial growth factor in metastatic melanoma", Br. J. Cancer 76(7), 930-934.
8. Shibusa, T., Shijuba, N. and Abe, S. (1998) "Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma", Clin. Cancer Res. 4, 1483-1487.
9. Takahashi, Y., Tucher, S.L., Kitadai, Y., et al. (1997) "Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer", Arch. Surg. 132, 541-546.
10. Toi, M., Taniguchi, T., Yamamoto, Y., et al. (1998) "Clinical significance of the determination of angiogenic factors", Br. J. Cancer 77(6), 998-1002.
11. The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage", Cancer 49, 2112-2135.
12. Shipp, M.A., Harrington, D.L. and Anderson, J. (1993) "Development of practice model for aggressive lymphoma", N. Engl. J. Med. 329, 987-994.
13. Cheson, B.D., Horning, S.J., Coiffier, B., et al. (1999) "Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphomas", J. Clin. Oncol. 17, 1244-1253.
14. Eppenberger, U., Kueng, W., Schlaeppi, J.M., et al. (1998) "Markers of tumor angiogenesis and proteolysis independently. Define high and low-risk subjects of node-negative breast cancer", J. Clin. Oncol. 16, 3129-3136.
15. Harok, E.R., Leek, R., Klenk, N., et al. (1992) "Angiogenesis, assessed by platelet/endothelial cell adhesion molecular antibodies, as indicator of a node metastases and survival in breast cancer", Lancet 340, 1220-1224.
16. Linderholm, B., Towelin, B., Grankerist, K. and Henriksson, R. (1998) "Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma", J. Clin. Oncol. 16, 3121-3128.
17. Wainer, N., Sample, J.P., Welch, W.R. and Folkman, J. (1991) "Tumor angiogenesis and metastasis correlation in invasive breast carcinoma", N. Engl. J. Med. 324, 1-8.
18. Macchiarini, P., Fortanini, G., Hardin, M.J., et al. (1992) "Relation of neovascularisation to metastasis of non-small cell lung cancer", Lancet 340, 145-146.
19. Panzella, F., Bacco, A.D., Andreola, S., et al. (1996) "Angiogenesis in primary lung cancer and lung secondaries", Eur. J. Cancer 32A(14), 2494-2500.
20. Yamazaki, K., Abe, S., Takekoma, H., et al. (1994) "Tumor angiogenesis in lung adenocarcinoma", Cancer 74, 2245-2250.
21. Sato, F., Shimad, T., Wetanebe, G., et al. (1999) "Expression of vascular endothelial growth factor, matrix metallo proteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer", Br. J. Cancer 80(9), 1366-1372.
22. Takano, S., Yoshii, Y., Kondo, S., et al. (1996) "Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients", Cancer Res. 56, 2185-2190.
23. Graham, C.H., Rivers, J., Kerbel, R.S., et al. (1994) "Extend of vascularization as a prognostic indicator in thin (<76 mm) malign melanoma", Am. J. Pathol. 145(3), 510-514.
24. Fukuda, S., Shrahama, T., Imazono, Y., et al. (1999) "Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease", Cancer 85, 1323-1330.
25. Chung, Y.S., Maeda, K. and Sowa, M. (1996) "Prognostic value of angiogenesis in gastrointestinal tumors", Eur. J. Cancer 14(32A), 2501-2505.
26. Saito, H., Tsusitoni, S., Ikeguchi, M., et al. (1998) "Relationship between the expression of vascular endothelial growth factor and the density of dentritic cells in gastric adenocarcinoma", Br. J. Cancer 78(12), 1573-1577.
27. Olson, T.A., Mobanraj, D., Carson, L.F. and Ramorkrishnon, S. (1994) "Vascular permeability factor gene expression in normal and neoplastic human ovaries", Cancer Res. 54, 276-280.
28. Ogawa, S., Kaku, T., Kobayashi, H., et al. (2002) "Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma", Cancer Lett. 176(1), 111-118.
29. Ribatti, D., Vacca, A., Quondamateo, F., et al. (1999) "Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma", Br. J. Cancer 79(3/4), 451-455.
30. Vacca, A., Ribatti, D., Rancall, L., et al. (1994) "Bone marrow angiogenesis and progression in multiple myeloma", Br. J. Haematol. 87, 503-506.
31. Rajkumar, S.V. and Kyle, R.A. (2001) "Angiogenesis in multiple myeloma", Semin. Oncol. 28(6), 560-564.
32. Paydas, S., Zorludemir, S., Baslamisli, F. and Tuncer, I. (2002) "Vascular endothelial growth factor(VEGF) expression in plasmacytoma", Leuk. Lymphoma 43(1), 139-143.
33. Pruneri, G., Bertolini, F., Soligo, D., et al. (1999) "Angiogenesis in myelodysplastic syndromes", Br. J. Cancer 81(8), 1398-1401.
34. Korkolopoulo, P., Apostolidou, E., Pavlopoulos, P.M., et al. (2001) "Prognostic evaluation of the microvascular network in myelodysplastic syndromes", Leukemia 15(9), 1369-1376.
35. Bairey, O., Zimra, Y., Kaganovsky, E., Shaklai, M., et al. (2000) "Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphoma", Med. Oncol. 17(4), 314-318.
36. Ribatti, D., Vacca, A., Marzullo, A., et al. (2000) "Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas", Int. J. Cancer 85(2), 171-175.
37. Ribatti, D., Vacca, A., Nico, B., et al. (1996) "Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study", Eur. J. Haematol. 56(1-2), 45-53.
38. Vacca, A., Ribatti, D., Fanelli, M., et al. (1996) "Expression of tenascin is related to histologic malignancy and angiogenesis in B-cell non-Hodgkin's lymphomas", Leuk. Lymphoma 22(5-6), 473-481.
39. List, A.F. (2001) "Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies", Oncologist 6(Suppl. 5), 24-31.
40. Foss, H.D., Aravjo, I., Demel, G., et al. (1997) "Expression of vascular endothelial growth factor in lymphomas and Castleman disease", J. Pathol. 183, 44-50.
41. Aoki, Y. and Tosato, G. (2001) "Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas", Leuk. Lymphoma 41(3-4), 229-237.
42. Bertolini, F., Paolucci, M., Peccetori, F. et al. (1999) "Angiogenic growth factors in non-Hodgkin's lymphoma." 4th.Congress of the European Haematology Association (EHA), June 9-12, Barcelona, Spain. Abstract 55-0508.
43. Potti, A., Ganti, A.K., Kargas, S. and Koch, M. (2002) "Immunhistochemical detection of c kit(CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma", Anticancer Res. 22(5), 2899-2901.
44. Niitsu, N., Okamato, M., Nakamine, H., et al. (2002) "Simultaneous elevation of serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of in aggressive non-Hodgkin's lymphoma", Eur. J. Haematol. 68(2), 91-100.
45. Hayashibra, T., Yamada, Y., Onimura, Y., et al. (2002) "Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukemia cell invasion", Br. J. Haematol. 116(1), 94-102.